ORCLSeptember 14, 2026 at 2:08 PM UTCSoftware & Services

Ellison Cancels $7.5B Oracle Stock Sale, Removing One Dilution Overhang but Not the Capex Math

Read source article

What happened

Larry Ellison scrapped a planned $7.5 billion Oracle stock sale just one day after it became public, removing a near-term supply overhang from the shares. The rapid reversal likely reflects either a desire to avoid sending a negative signal to investors or an unwillingness to sell at the stock's depressed levels following its sharp decline from 2025 highs. Regardless of the motivation, the cancellation does not alter Oracle's fundamental challenge: massive AI-driven capex requires continued financing, and free cash flow remains deeply negative at -$23.7 billion in FY2026. The DeepValue master report already identified a separate $20 billion at-the-market equity program as a key dilution risk, and Ellison's personal sale would have added to that supply. While the news is mildly positive, the core thesis—that Oracle must prove faster backlog conversion and cash generation—remains unchanged.

Implication

Investors should view the canceled insider sale as a minor positive that reduces immediate supply but not the central issue of funding a $55B+ annual capex program with negative free cash flow. The stock's attractiveness still hinges on Q1 FY2027 cloud growth landing in the 58%–64% guided range, evidence of higher customer prepayments, and no meaningful use of the $20B ATM. If those checkpoints fail, dilution and leverage risks reassert themselves regardless of Ellison's personal decision. Conversely, a strong quarterly report combined with continued insider confidence could support a re-rating toward the bull case of $190. For now, the WAIT rating stands, with a re-assessment window of 3–6 months and attractive entry near $135.

Thesis delta

The cancellation removes a specific near-term dilution risk associated with Ellison's personal holdings, but it does not change Oracle's structural funding needs or the risk that the company will tap its $20B ATM program. The existing WAIT rating remains appropriate because the key drivers—RPO conversion, customer prepayments, and capex efficiency—are unaffected by this announcement. If anything, it slightly reduces the probability of near-term insider-driven supply, but not enough to alter the fundamental calculus.

Confidence

Medium